Position
GenTrust, LLC in Recursion Pharmaceuticals In
Back to the book · All holders of RECURSION PHARMACEUTICALS IN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$12.7K$4.09 → $3.07
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.4K | $50.9K | — | — | — | 0.0% |
| Q1 2026 | 14.2K | $43.7K | $3.07 | −$12.7K | $5.55K | 0.0% |